Vanguard Group
ALDX icon

Vanguard Group’s Aldeyra Therapeutics ALDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$13.4M Sell
3,501,593
-216,425
-6% -$829K ﹤0.01% 2751
2025
Q1
$21.4M Sell
3,718,018
-38,770
-1% -$223K ﹤0.01% 2477
2024
Q4
$18.7M Sell
3,756,788
-3,831
-0.1% -$19.1K ﹤0.01% 2620
2024
Q3
$20.3M Buy
3,760,619
+18,233
+0.5% +$98.3K ﹤0.01% 2587
2024
Q2
$12.4M Sell
3,742,386
-126,693
-3% -$419K ﹤0.01% 2796
2024
Q1
$12.7M Sell
3,869,079
-58,518
-1% -$191K ﹤0.01% 2834
2023
Q4
$13.8M Buy
3,927,597
+740,177
+23% +$2.6M ﹤0.01% 2777
2023
Q3
$21.3M Buy
3,187,420
+7,226
+0.2% +$48.3K ﹤0.01% 2523
2023
Q2
$26.7M Buy
3,180,194
+681,033
+27% +$5.71M ﹤0.01% 2468
2023
Q1
$24.8M Buy
2,499,161
+6,892
+0.3% +$68.4K ﹤0.01% 2498
2022
Q4
$17.3M Sell
2,492,269
-23,615
-0.9% -$164K ﹤0.01% 2685
2022
Q3
$13.4M Buy
2,515,884
+79,126
+3% +$423K ﹤0.01% 2812
2022
Q2
$9.72M Sell
2,436,758
-524,877
-18% -$2.09M ﹤0.01% 3002
2022
Q1
$13.2M Buy
2,961,635
+147,711
+5% +$657K ﹤0.01% 3007
2021
Q4
$11.3M Buy
2,813,924
+86,528
+3% +$346K ﹤0.01% 3145
2021
Q3
$23.9M Buy
2,727,396
+30,946
+1% +$272K ﹤0.01% 2757
2021
Q2
$30.6M Buy
2,696,450
+643,955
+31% +$7.3M ﹤0.01% 2621
2021
Q1
$24.4M Buy
2,052,495
+436,490
+27% +$5.19M ﹤0.01% 2680
2020
Q4
$11.1M Sell
1,616,005
-35,753
-2% -$245K ﹤0.01% 2941
2020
Q3
$12.2M Buy
1,651,758
+618,787
+60% +$4.59M ﹤0.01% 2687
2020
Q2
$4.31M Sell
1,032,971
-93,671
-8% -$391K ﹤0.01% 3165
2020
Q1
$2.78M Buy
1,126,642
+1,310
+0.1% +$3.24K ﹤0.01% 3205
2019
Q4
$6.54M Sell
1,125,332
-3,285
-0.3% -$19.1K ﹤0.01% 3065
2019
Q3
$5.95M Buy
1,128,617
+16,673
+1% +$87.9K ﹤0.01% 3073
2019
Q2
$6.67M Buy
1,111,944
+42,869
+4% +$257K ﹤0.01% 3066
2019
Q1
$9.65M Sell
1,069,075
-30,545
-3% -$276K ﹤0.01% 2845
2018
Q4
$9.13M Buy
1,099,620
+151,744
+16% +$1.26M ﹤0.01% 2810
2018
Q3
$13.1M Buy
947,876
+193,707
+26% +$2.67M ﹤0.01% 2791
2018
Q2
$6M Buy
754,169
+56,535
+8% +$449K ﹤0.01% 3144
2018
Q1
$5.23M Sell
697,634
-900
-0.1% -$6.75K ﹤0.01% 3136
2017
Q4
$4.75M Buy
698,534
+227,503
+48% +$1.55M ﹤0.01% 3156
2017
Q3
$3.39M Buy
471,031
+166,398
+55% +$1.2M ﹤0.01% 3249
2017
Q2
$1.43M Buy
304,633
+9,407
+3% +$44.2K ﹤0.01% 3484
2017
Q1
$1.48M Buy
295,226
+149,754
+103% +$749K ﹤0.01% 3470
2016
Q4
$779K Buy
145,472
+12,586
+9% +$67.4K ﹤0.01% 3637
2016
Q3
$1.04M Buy
132,886
+7,761
+6% +$60.9K ﹤0.01% 3562
2016
Q2
$712K Buy
125,125
+3,718
+3% +$21.2K ﹤0.01% 3701
2016
Q1
$508K Buy
121,407
+3,067
+3% +$12.8K ﹤0.01% 3788
2015
Q4
$802K Buy
118,340
+11,070
+10% +$75K ﹤0.01% 3689
2015
Q3
$626K Buy
107,270
+3,800
+4% +$22.2K ﹤0.01% 3785
2015
Q2
$802K Buy
+103,470
New +$802K ﹤0.01% 3729